1 |
Endo, A. : The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569 (1992)
PUBMED
|
2 |
Wolozin, B., Wang, S. W., Li, N. C., Lee, A., Lee, T. A. and Kazis, L. E. : Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med. 5, 20 (2007)
|
3 |
Ohnaka, K. and Takayanagi, R. : Statin and BMP. Clin. Calcium. 14, 286 (2004)
PUBMED
|
4 |
Ruiz-Gaspa, S., Nogues, X., Enjuanes, A., Monllau, J. C., Blanch, J., Carreras, R., Mellibovsky, L., Grinberg, D., Balcells, S., Dez-Perez, A. and Pedro-Botet, J. : Simvastatin and atorvastatin enhance gene expression of collagen type 1 and
osteocalcin in primary human osteoblasts and MG-63 cultures. J. Cell. Biochem. 101, 1430 (2007)
DOI
ScienceOn
|
5 |
Song, C., Wang, J., Song, Q., Li, X., Chen, Z., Ma, Q., Liu, Z., Jia, H. and Dang, G. : Simvastatin induces estrogen receptoralpha (ER-alpha) in murine bone marrow stromal cells. J. Bone Miner. Metab. 26, 213 (2008)
DOI
PUBMED
|
6 |
Majima, T., Shimatsu, A., Komatsu, Y., Satoh, N., Fukao, A., Ninomiya, K., Matsumura, T. and Nakao, K. : Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia. Intern. Med. 46, 1967 (2007)
DOI
ScienceOn
|
7 |
Cushenberry, L. M. and de Bittner, M. R. : Potential use of HMG-CoA reductase inhibitors for osteoporosis. Ann. Pharmacother. 36, 671 (2002)
DOI
ScienceOn
|
8 |
Gonyeau, M. J. : Statins and osteoporosis: a clinical review. Pharmacotherapy 25, 228 (2005)
DOI
PUBMED
ScienceOn
|
9 |
Schlienger, R. G. and Meier, C. R. : HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture? Drugs Aging 20, 321 (2003)
DOI
ScienceOn
|
10 |
Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M. and Gutierrez, G. : Stimulation of bone formation in vitro and in rodents by statins. Science 286, 1946 (1999)
DOI
PUBMED
ScienceOn
|
11 |
Nichols, R., Hopman, W. M., Morton, A. R., Harman, G. J. and Holden, R. M. : Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients. Hemodial. Int. 12, 175 (2008)
|
12 |
Richard, E., Scranton, M. D., Melissa, Y., Elizabeth, L., Daniel, S., David, G. and Michael, G. : Statin Use and Fracture Risk. Arch. Intern. Med. 165, 2007 (2005)
DOI
ScienceOn
|
13 |
Schoofs, M. W., Sturkenboom, M. C., van der Klift, M., Hofman, A., Pols, H. A. and Stricker, B. H. : HMG-CoA reductase inhibitors and the risk of vertebral fracture. J. Bone Miner. Res. 19, 152 (2004)
|
14 |
Moriyama, Y., Ayukawa, Y., Ogino, Y., Atsuta, I. and Koyano, K. : Topical application of statin affects bone healing around implants. Clin. Oral Implants Res. 19, 600 (2008)
DOI
ScienceOn
|
15 |
LaCroix, A. Z., Cauley, J. A., Pettinger, M., Hsia, J., Bauer D. C., McGowan, J., Chen, Z., Lewis, C. E., McNeeley, S. G., Passaro, M. D. and Jackson, R. D. : Statin use, clinical fracture, and bone density in postmenopausal women: results from the women's health initiative observational study. Ann. Intern. Med. 139, 97 (2003)
DOI
PUBMED
ScienceOn
|
16 |
Mauro, V. F. and MacDonald, J. L. : Simvastatin: a review of its pharmacology and clinical use. Dalian Inst. Chem. Phys. 25, 257 (1991)
|
17 |
Gaw, A., Packard, C. J. and Shepherd, J. : Statins; The HMGCoA Reductase Inhibitors in Perspective. 2nd edition. London, Martin Dunitz, p340 (2004)
|
18 |
Bielinska, A. and Gluszko, P. : Statins - are they potentially useful in rheumatology? Pol. Arch. Med. Wewn. 117, 420 (2007)
|
19 |
Shaw, S. M., Fildes, J. E., Yonan, N. and Williams, S. G. : Pleiotropic effects and cholesterol-lowering therapy. Cardiology 112, 4 (2008)
DOI
ScienceOn
|
20 |
Fried, L. F. : Effects of HMG-CoA reductase inhibitors(statins) on progression of kidney disease. Kidney Int. 74, 571 (2008)
DOI
PUBMED
ScienceOn
|
21 |
Rejnmark, L., Buus, N. H., Vestergaard, P., Andreasen, F., Larsen, M. L. and Mosekilde, L. : Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur. J Clin. Invest. 32, 581 (2002)
DOI
ScienceOn
|
22 |
De Leo, V., Morgante, G., la Marca, A., Lanzetta, D., Cobellis, L. and Petraglia, F. : Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density. Gynecol. Endocrinol. 17, 329 (2003)
|
23 |
Wang, P. S., Solomon, D. H., Mogun, H. and Avorn, J. : HMGCoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283, 3211 (2000)
DOI
ScienceOn
|
24 |
Svejda, P., Soska, V. and Soucek, M. : The impact of statin therapy on bone density changes in postmenopausal women. Vnitr. Lek. 53, 1064 (2007)
|
25 |
Coons, J. C. : Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management. Ann. Pharmacother. 36, 3260 (2002)
|
26 |
Gutierrez, G. E., Edwards, J. R., Garrett, I. R., Nyman, J. S., McCluskey, B., Rossini, G., Flores, A., Neidre, D. B. and Mundy, G. R. : Transdermal lovastatin enhances fracture repair in rats. J. Bone Miner. Res. 23, 1722 (2008)
DOI
ScienceOn
|
27 |
Skoglund, B. and Aspenberg, P. : Locally applied Simvastatin improves fracture healing in mice. BMC Musculoskelet. Disord. 8, 98 (2007)
DOI
PUBMED
ScienceOn
|
28 |
Yazawa, H., Zimmermann, B., Asami, Y. and Bernimoulin, J. P. : Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. J. Periodontol. 76, 295 (2005)
DOI
ScienceOn
|
29 |
Jones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A. and Blasetto, J. W. : Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am. J. Cardiol. 92, 152 (2003)
|
30 |
Benoit, D. S., Nuttelman, C. R., Collins, S. D. and Anseth, K. S. : Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 27, 6102
(2006)
DOI
ScienceOn
|
31 |
Ray, W. A., Daugherty, J. R. and Griffin, M. R. : Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj. Prev. 8, 276 (2002)
DOI
ScienceOn
|
32 |
OzeI., KiliE., GmC. and Gze, F. : Effect of local simvastatin application on mandibular defects. J. Craniofac. Surg. 18, 546 (2007)
DOI
ScienceOn
|
33 |
Bocan, T. M. : Pleiotropic effects of HMG-CoA reductase inhibitors. Curr. Opin. Investig. Drugs 3, 1312 (2002)
|
34 |
Lee, O. K., Ko, Y. C., Kuo, T. K., Chou, S. H., Li, H. J., Chen, W. M., Chen, T. H. and Su, Y. : Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells. Cell Biochem. 93, 917 (2004)
DOI
ScienceOn
|
35 |
Ahn, K. S., Sethi, G., Chaturvedi, M. M. and Aggarwal, B. B. : Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int. J. Cancer 123, 1733 (2008)
DOI
ScienceOn
|
36 |
Kolanczyk, M., Khnisch, J., Kossler, N., Osswald, M., Stumpp, S., Thurisch, B., Kornak, U. and Mundlos, S. : Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin. BMC Medicine 6, 21 (2008)
|
37 |
Rejnmark, L., Vestergaard, P. and Mosekilde, L. : Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study. Calcif, Tissue Int. 79, 27 (2006)
DOI
ScienceOn
|
38 |
Robert, H. and Knopp. : Drug Treatment of Lipid Disorders. N. Engl. J. Med. 341, 2020 (1999)
DOI
PUBMED
|
39 |
Viccica, G., Vignali, E. and Marcocci, C. : Role of the cholesterol biosynthetic pathway in osteoblastic differentiation. J. Endocrinol. Invest. 30, 8 (2007)
PUBMED
|
40 |
Tanriverdi, H. A., Barut, A. and Sarikaya, S. : Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. Eur. J. Obstet. Gynecol. Reprod. Biol. 120, 63 (2005)
DOI
ScienceOn
|
41 |
Adah, F., Benghuzzi, H., Tucci, M., Russell, G. and England, B. : Cholesterol production inhibitor (statin) increased bone healing in surgically created femoral defect in an animal model. Biomed. Sci. Instrum. 43, 95 (2007)
PUBMED
|
42 |
Mauro, V. F. : Clinical pharmacokinetics and practical applications of simvastatin. Clin. Pharmacokinet. 24, 195 (1993)
DOI
PUBMED
ScienceOn
|
43 |
Nyan, M., Sato, D., Oda, M., Machida, T., Kobayashi, H., Nakamura, T. and Kasugai, S. : Bone formation with the combination of simvastatin and calcium sulfate in critical-sized rat calvarial defect. J. Pharmacol. Sci. 104, 384 (2007)
DOI
ScienceOn
|
44 |
Vickers, S., Duncan, C. A., Chen, I. W., Rosegay, A. and Duggan, D. E. : Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab. Dispos. 18, 138 (1990)
|
45 |
Funkhouser, H. L., Adera, T. and Adler, R. A. : Effect of HMGCoA reductase inhibitors (statins) on bone mineral density. J. Clin. Densitom. 5, 151 (2002)
DOI
ScienceOn
|
46 |
Jones, P. H., Hunninghake, D. B., Ferdinand, K. C., Stein, E. A., Gold, A., Caplan, R. J. and Blasetto, J. W. : : Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Clin. Ther. 26, 1388 (2004)
DOI
PUBMED
ScienceOn
|
47 |
Julie, A. P., Mark, A. K., Margaret, J. H., Kerrie, M. S. and Geoffrey, C. N. : Statin use, bone mineral density, and fracture risk: Geelong osteoporosis study. Arch. Intern. Med. 162, 537 (2002)
DOI
ScienceOn
|
48 |
Ma, B., Clarke, S. A., Brooks, R. A. and Rushton, N. : The effect of simvastatin on bone formation and ceramic resorption in a peri-implant defect model. Acta. Biomater. 4, 149 (2008)
DOI
ScienceOn
|
49 |
Wong, R. W. and Rabie, A. B. : Statin-induced osteogenesis uses in orthodontics: a scientific review. World J. Orthod. 7, 35 (2006)
PUBMED
|
50 |
Staal, A., Frith, J. C., French, M. H., Swartz, J., Gngr, T., Harrity, T. W., Tamasi, J., Rogers, M. J. and Feyen, J. H. : The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J. Bone Miner. Res. 18, 88 (2003)
DOI
ScienceOn
|
51 |
Jadhav, S. B., Narayana Murthy, P. S., Singh, M. M. and Jain, G. K. : Distribution of lovastatin to bone and its effect on bone turnover in rats. J. Pharm. Pharmacol. 58, 1415 (2006)
DOI
ScienceOn
|
52 |
Richard, N. M., Glen, B., Jean, K. C., Alan, M. H., Thomas, T. N. and John, C. V. : Biosynthesis of the hypocholesterolemic agent mevinolin by Aspergillus terreus. Determination of the origin of carbon, hydrogen and oxygen by 13C NMR and mass spectrometry. J. Am. Chem. Soc. 107, 3694 (1985)
DOI
|
53 |
Baldini, V., Mastropasqua, M., Francucci, C. M. and D'Erasmo, E. : Cardiovascular disease and osteoporosis. J. Endocrinol. Invest. 28, 69 (2005)
PUBMED
|
54 |
Horiuchi, N. and Maeda, T. : Statins and bone metabolism. Oral Dis. 12, 85 (2006)
DOI
ScienceOn
|
55 |
Bharti, A. C., Takada, Y. and Aggarwal, B. B. : Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 172, 5940 (2004)
DOI
|
56 |
Cruz, A. C. and Gruber, B. L. : Statins and osteoporosis: can these lipid-lowering drugs also bolster bones? Cleve. Clin. J. Med. 69, 277 (2002)
DOI
ScienceOn
|
57 |
Yaturu, S. : Skeletal effects of statins. Endocr. Pract. 9, 315 (2003)
DOI
ScienceOn
|
58 |
Lennernas, H. and Fager, G. : Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin. Pharmacokinet. 32, 403 (1997)
DOI
ScienceOn
|
59 |
Meier, C. R., Schlienger, R. G., Kraenzlin, M. E., Schlegel, B. and Jick, H. : HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283, 3205 (2000)
|
60 |
Gutierrez, G. E., Lalka, D., Garrett, I. R., Rossini, G. and Mundy, G. R. : Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos. Int. 17, 1033 (2006)
DOI
ScienceOn
|
61 |
Skoglund, B., Forslund, C. and Aspenberg, P. : Simvastatin improves fracture healing in mice. J. Bone Miner. Res. 17, 2004 (2002)
DOI
ScienceOn
|
62 |
von Knoch, F., Wedemeyer, C., Heckelei, A., Saxler, G., Hilken, G., Brankamp, J., Sterner, T., Landgraeber, S., Henschke, F., Ler, F. and von Knoch, M. : Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis. Biomaterials 26, 5783 (2005)
DOI
ScienceOn
|
63 |
Garrett, I. R., Gutierrez, G. E., Rossini, G., Nyman, J., McCluskey, B., Flores, A. and Mundy, G. R. : Locally delivered lovastatin nanoparticles enhance fracture healing in rats. J. Orthop. Res. 25, 1351 (2007)
DOI
ScienceOn
|
64 |
Yao, W., Farmer, R., Cooper, R., Chmielewski, P. A., Tian, X. Y., Setterberg, R. B., Jee, W. S. and Lundy, M. W. : Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats. J. Musculoskelet. Neuronal. Interact. 6, 277 (2006)
|
65 |
Bone, H. G., Kiel, D. P., Lindsay, R. S., Lewiecki, E. M., Bolognese, M. A., Leary, E. T., Lowe, W. and McClung, M. R. : Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: A double-blind, placebo-controlled, dose-ranging trial. J. Clin. Endocrinol. Metab. 92, 4671 (2007)
DOI
ScienceOn
|
66 |
Sirola, J., Sirola, J., Honkanen, R., Krger, H., Jurvelin, J. S., MenpP. and Saarikoski, S. : Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women. Osteoporos. Int. 13, 537 (2002)
DOI
ScienceOn
|
67 |
Serin-Kilicoglu, S. and Erdemli, E. : New addition to the statin's effect. J. Trauma 63, 187 (2007)
DOI
ScienceOn
|